The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sorafenib administered using a high-dose, pulsatile regimen in patients with advanced solid malignancies: A phase I exposure escalation study.
 
Lemonitsa Hillegonda Mammatas
No Relationships to Disclose
 
Anthe S. Zandvliet
Travel, Accommodations, Expenses - Roche (I)
 
Maria Rovithi
No Relationships to Disclose
 
Richard Honeywell
Employment - Lundbeck (I)
Stock and Other Ownership Interests - Merck KGaA (I)
Travel, Accommodations, Expenses - Lundbeck (I)
 
Eleonora Swart
Employment - Pfizer (I)
Consulting or Advisory Role - Merck (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Roche
 
Godefridus J. Peters
No Relationships to Disclose
 
Catharina Wilhelmina Menke
Research Funding - GlaxoSmithKline (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer; Roche
 
Henk M.W. Verheul
Consulting or Advisory Role - Boehringer Ingelheim (Inst); Merck (Inst); Pfizer (Inst)
Research Funding - Amgen (Inst); Immunovo (Inst); Novartis (Inst); Roche (Inst); Vitromics (Inst)